Immunopharmacology And Immunotoxicology

The journal Immunopharmacology and Immunotoxicology is devoted to pre-clinical and clinical drug discovery and development targeting the immune system. Research related to the immunoregulatory effects of various compounds, including small-molecule drugs and biologics, on immunocompetent cells and immune responses, as well as the immunotoxicity exerted by xenobiotics and drugs. Only research that describe the mechanisms of specific compounds (not extracts) is of interest to the journal.

The journal will prioritise preclinical and clinical studies on immunotherapy of disorders such as chronic inflammation, allergy, autoimmunity, cancer etc. The effects of small-drugs, vaccines and biologics against central immunological targets as well as cell-based therapy, including dendritic cell therapy, T cell adoptive transfer and stem cell therapy, are topics of particular interest. Publications pointing towards potential new drug targets within the immune system or novel technology for immunopharmacological drug development are also welcome.

With an immunoscience focus on drug development, immunotherapy and toxicology, the journal will cover areas such as infection, allergy, inflammation, tumor immunology, degenerative disorders, immunodeficiencies, neurology, atherosclerosis and more.

Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, commentaries, mini-reviews, reviews, clinical trials and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).

中文简介Magazine introduction

《免疫药理学和免疫毒理学》杂志致力于针对免疫系统的临床前和临床药物发现和开发。研究涉及各种化合物（包括小分子药物和生物制剂）对免疫活性细胞和免疫反应的免疫调节作用，以及异生物质和药物的免疫毒性。该期刊只对描述特定化合物（而非提取物）机制的研究感兴趣。

该杂志将重点关注慢性炎症、过敏、自身免疫、癌症等疾病的免疫治疗的临床前和临床研究。小药、疫苗和生物制剂对中枢免疫靶点的影响以及基于细胞的治疗，包括树突状细胞疗法、T 细胞过继转移和干细胞疗法是特别令人感兴趣的主题。也欢迎发表指出免疫系统内潜在新药靶点或免疫药理学药物开发新技术的出版物。

该期刊专注于药物开发、免疫疗法和毒理学，涵盖感染、过敏、炎症、肿瘤免疫学、退行性疾病、免疫缺陷、神经病学、动脉粥样硬化等领域。

Immunopharmacology and Immunotoxicology 将接受原始手稿、简短交流、评论、小型评论、评论、临床试验和临床案例，条件是报告的结果基于原始、临床或尚未发表的基础研究以任何语言在任何期刊的其他地方（与科学会议和专题讨论会交流的论文有关的摘要形式除外）。

期刊简述Magazine introduction

Immunopharmacology And Immunotoxicology创刊于1987年，由TAYLOR & FRANCIS LTD出版商出版，收稿方向涵盖医学 - 毒理学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度偏慢,4-8周，影响因子指数3.300，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。

中科院分区Magazine introduction

大类学科	小类学科	分区	Top期刊	综述期刊
医学	IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学	4区	是	是

名词解释：
中科院分区也叫中科院JCR分区，基础版分为13个大类学科，然后按照各类期刊影响因子分别将每个类别分为四个区，影响因子5%为1区，6%-20%为2区，21%-50%为3区，其余为4区。

JCR分区Magazine introduction

大类学科	小类学科	分区
医学	IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学	4区

名词解释：
JCR没有设置大类，只分为176个具体学科，按当期（1年）的影响因子进行分区；JCR是按照“平均主义”思想，根据刊物IF的高至低平均划分4个区，每个区含有该领域总量25%的期刊。中科院的分区如同社会阶层的金字塔结构，1区只有5%的顶级期刊， 2~4区期刊数量也逐层增加,所以中科院的1区和2区杂志很少，杂志质量相对也高，基本都是本领域的顶级期刊。

期刊名称	领域	中科院分区	影响因子
Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I P Pavlova	医学	4区	0.300
Anadolu Psikiyatri Dergisi-anatolian Journal Of Psychiatry	医学	4区	0.660
International Journal Of Circumpolar Health	医学	4区	1.300
Annali Dell Istituto Superiore Di Sanita	医学	4区	2.100
Transactions Of The Royal Society Of Tropical Medicine And Hygiene	医学	4区	2.200
Annali Dell Istituto Superiore Di Sanita	医学	4区	2.100